Amino acid replacement: W817term.
G2220195A
W817term | mio-PA
W817term
G to A nucleotide change at the second or third position of the wild type Trp codon leads to a nonsense mutation (exact site of mutation unspecified). The mutation was annotated at the second base of the codon.
Egg chambers containing germline clones of mio2 are dramatically smaller and have nurse cells with decreased ploidy values relative to adjacent wild type egg chambers. Clones in somatic cells, including the fat body and somatic cells of the ovary, show only a small decrease, if any, in cell size and ploidy.
Ovarian cysts, but not fat bodies, from mio2/Df(2L)Exel6007 animals accumulate autolysosomes.
Egg chambers from mio1/mio2 females often develop without an oocyte and cease to develop beyond stage 5 or 6 of oogenesis.
In mio1/mio2 mutants, the vast majority of egg chambers arrest prior to stage 5 of oogenesis, well before the start of vitellogenesis in stage 7.
In homozygous mio2 egg chambers, the centrioles fail to migrate to the posterior of the oocyte. In the mutant egg chambers, the distribution of microtubules is frequently disorganised.
mio2 mutants have a similar frequency of single-strand annealing repair (SSA) compared to controls in a P{wIw.FRT} hemizygous assay to study DNA double-stranded break repair when assayed at 38oC, but show a reduction in SSA frequency when assayed at 32oC.
90% of egg chambers in mio1 homozygotes have 16-polyploid nurse cells and no oocyte. These egg chambers rarely develop beyond stage 5 of oogenesis. The severity of this phenotype not significantly different in mio2/Df(2L)yan-J2, suggesting that this allele is a genetically null.
mio2/mio1 has egg chamber phenotype, suppressible by Scer\GAL4nanos.PG/Nprl2RNAi.UAS.V20
mio2/mio1 has egg chamber phenotype, suppressible by Scer\GAL4nanos.PG/Nprl3RNAi.UAS.V20
mio2/mio1 has egg chamber phenotype, suppressible by Scer\GAL4nanos.PG/Tsc1GL00012
mio2/mio1 has egg chamber phenotype, suppressible | partially by Nup44A[+]/Nup44AEP2417
mio2/mio1 has egg chamber phenotype, suppressible by Df(2R)ED1735/+
mio2/mio1 has egg chamber phenotype, suppressible by Nup44AΔ15/Nup44A[+]
mio2 has egg chamber phenotype, suppressible by mei-P22P22
mio2 has egg chamber phenotype, suppressible by mei-W681
mio2 has nurse cell phenotype, suppressible by mei-P22[+]/mei-P22P22
mio2 has nurse cell phenotype, suppressible by mei-P22P22/mei-P22P22
mio2 has nurse cell phenotype, suppressible by mei-W68[+]/mei-W681
mio2 has nurse cell phenotype, suppressible by mei-W681/mei-W681
mio2 has nurse cell phenotype, suppressible by mei-W68[+]/mei-W68k05603
mio2 has oocyte phenotype, suppressible by mei-P22[+]/mei-P22P22
mio2 has oocyte phenotype, suppressible by mei-P22P22/mei-P22P22
mio2 has oocyte phenotype, suppressible by mei-W68[+]/mei-W68k05603
mio2/mio1 has nurse cell phenotype, suppressible | partially by mei-W68[+]/mei-W681
mio2/mio1 has nurse cell phenotype, suppressible | partially by mei-W68[+]/mei-W68k05603
mio2/mio1 has oocyte phenotype, suppressible | partially by mei-W68[+]/mei-W68k05603
mio2 has ovary phenotype, non-suppressible by Scer\GAL4VP16.nanos.UTR/Nprl2RNAi.UAS.V20
mio2 has ovary phenotype, non-suppressible by Scer\GAL4VP16.nanos.UTR/Nprl3RNAi.UAS.V20
mio2 has nurse cell phenotype, non-suppressible by mei-41[+]/mei-4129D
mio2 has nurse cell phenotype, non-suppressible by mei-4129D/mei-4129D
mio2 is an enhancer of egg chamber phenotype of Nup44AΔ15
egl1, mio2 has cystoblast phenotype
Expression of Nprl2dsRNA.shRNA.Scer\UAS or Nprl3dsRNA.shRNA.Scer\UAS driven by Scer\GAL4nos.UTR.T:Hsim\VP16 does not suppress accumulation of acidic puncta in mio2/mio2 ovaries.
Nup44AEP2417/+ partially suppresses the mio1/mio2 oogenesis phenotype. In contrast to mio1/mio2 single mutants, egg chambers from Nup44AEP2417/+, mio1/mio2 females frequently progress through vitellogenesis to produce mature eggs. Moreover, a small percentage of the eggs laid by Nup44AEP2417/+, mio1/mio2 females hatch and develop into viable adults.
The percentage of mio1/mio2 mutant egg chambers with an oocyte increases 6-fold in a Df(2R)ED1735/+ genetic background.
The percentage of mio1/mio2 mutant egg chambers with an oocyte increases 6-fold in a Nup44AΔ15/+ genetic background.
Ovaries from mio2, Nup44AΔ15 double mutant females closely resemble those from Nup44AΔ15 single mutants, with 80% or egg chambers containing an oocyte and 20% containing 16 nurse cells and no obvious oocyte. However, ovaries from mio2, Nup44AΔ15 double homozygotes have fewer older egg chambers than Nup44AΔ15 single mutants.
Transformation of oocytes to nurse cells in mio2 homozygous females is partially suppressed by mei-W681/+, mei-W681/mei-W681, mei-P22P22/+, mei-P22P22/mei-P22P22 or mei-W68k05603/+, but not by mei-4129D/+ or mei-4129D/mei-4129D. The block in oogenesis at around stage 5 seen in mio2 homozygous females is also partially suppressed by mei-W681 or mei-P22P22, producing egg chambers that often undergo vitellogenesis and develop to the late stages of oogenesis. Transformation of oocytes to nurse cells in mio2/mio1 females is suppressed by mei-W681/+ or mei-W68k05603/+. mio2; egl1 double homozygotes have a phenotype significantly stronger than either single mutant: All cystoblasts lack obvious synaptonemal complexes.
mio2 is rescued by Scer\GAL4VP16.nanos.UTR/mioUASp.cIa
Mulligan